Catalent (CTLT)
(Delayed Data from NYSE)
$54.28 USD
+0.49 (0.91%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $54.28 0.00 (0.00%) 5:24 PM ET
2-Buy of 5 2
C Value F Growth C Momentum F VGM
Brokerage Reports
Catalent, Inc. [CTLT]
Reports for Purchase
Showing records 121 - 140 ( 216 total )
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Higher Growth at a Discount; Raise PT from $120 to $142
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Catalent, Inc.
Industry: Medical - Drugs
Bioproduction: ''Guten Morgan Europe'' - Positive 2021 Industry Guides from Lonza and Sartorius
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Catalent, Inc.
Industry: Medical - Drugs
Life Science Tools: DC Never Friendlier with Biden "American Rescue Plan"
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Catalent, Inc.
Industry: Medical - Drugs
D.C. Very Friendly with Biden "American Rescue Plan";
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Modeling COVID-19: Vaccine and Diagnostic Demand Outlook with Herd Immunity in 2021
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Assuming Co-Coverage and Upgrading to OW: ''Thermoesque'' Biologics Transformation
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department